Clinical trial

A Long-term Study for the Treatment of Painful Diabetic Neuropathy

NCT00641719

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Duloxetine hydrochloride Normalized identity: duloxetine hydrochlorideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Long-term Study for the Treatment of Painful Diabetic Neuropathy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE3

Conditions

Diabetic Neuropathiesunresolved

Interventions

Duloxetine hydrochlorideDRUG · verified · RxNorm: duloxetine hydrochloride

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Shionogicollaborator

Mapped research locations

TokyoJapan1 OsakaJapan1 FukuokaJapan1 KyotoJapan1 ChibaJapan1 HiroshimaJapan1 OkayamaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00641719 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.